
About ProteoGenex
ProteoGenex is a Healthcare company based in Culver City (United States) founded in 2003. Biological materials and clinical services are supplied for biomedical research. The company has 9 employees. ProteoGenex offers products and services including Fresh Frozen Tissues, FFPE Tissues, Blood Products, RNA and DNA, and Custom Collections. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Biorepository. Its legal entity is PROTEOGENEX, INC. Its competitors include GenVault Corporation, iSpecimen and ViaCell; 3 of its 3 listed competitors have raised funding.
Company details
ProteoGenex provides biological materials for biomedical research applications to biotechnology, pharmaceutical, and academic research organizations. The company offers fresh frozen tissue samples; FFPE tissue samples; biofluids, such as blood, bone marrows, urine, saliva, sputum, synovial, and cerebrospinal fluid; RNA and DNA samples; tissue microarrays; human primary cell lines derived from solid tumors and normal tissues; and custom-design human tissue-based research service (largest and fastest growing business segment) for various clinical conditions. It also provides clinical trail services, which include project management, clinical trial monitoring, safety surveillance, CTM and logistics, data management and biostatistics, quality assurance and audits, and regulatory affairs primarily in the areas of oncologyhematology, psychiatry, autoimmune disorders, cardiovascular diseases, and sitesinvestigators identification. The company claims to have over 200,000 individual biomaterials supported by extensive pathology and patient history documentation
- Headquarters Culver City, United States
- Employees 9
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Emailβ’β’β’β’β’β’β’β’
- Website proteogenex.com
- Social LinkedIn
- Legal Name Proteogenex, Inc.
- Employee Count9
Products & Services of ProteoGenex
ProteoGenex offers a comprehensive portfolio of products and services, including Fresh Frozen Tissues, FFPE Tissues, Blood Products, RNA and DNA, and Custom Collections.
Human tissues preserved for research and analysis purposes.
Formalin-fixed tissues for histological studies and diagnostics.
Whole blood, serum, and plasma for medical and research applications.
Extracted nucleic acids from human samples for scientific testing.
Tailored specimen procurement based on client specifications.
People of ProteoGenex
1 people are tracked at ProteoGenex (1 in leadership); the tracked headcount is 9.
| Name | Role | Group |
|---|---|---|
Mark Sjostrand | Head Of Business Development | Leadership |
Complete people profiles for ProteoGenex
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of ProteoGenex
ProteoGenex has 3 listed competitors in our database, 3 of them funded. They include GenVault Corporation, iSpecimen and ViaCell.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genvault.com | 2000 | Carlsbad, United States | $47.8M | Biosamples are stabilized, transported, stored, and retrieved by GenVault. | ||
| ispecimen.com | 2009 | Lexington, United States | $11.86M | 75 | Provider of a biorepository of human clinical specimens | |
| viacellinc.com | 1994 | Cambridge, United States | $63M | Provider of services for collecting and preserving umbilical cord blood stem cells |
Detailed competitors of ProteoGenex
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ProteoGenex
The website of ProteoGenex (proteogenex.com) receives about 2.5K visits a month and ranks #7,820,245 among all websites worldwide, #7,159 in Biotechnology and Pharmaceuticals.
- Monthly visits2.5K
▲ 16.3% vs previous month
- Global rank#7,820,245
among all websites
- Category rank#7,159
Health · Biotechnology and Pharmaceuticals
- Bounce rate39%
- Pages per visit1.5
- Average visit19 sec
- DevicesDesktop 17% Β· Mobile 83%
Websites whose visitors overlap most with ProteoGenex. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| crosnt.com | 100% | View details | |||
| ecrscorp.com | 98% | 12.7K | #1,252,459 | View details | |
| accelovance.com | 96% | View details | |||
sequentdevelopment.com | sequentdevelopment.com | 94% | β | ||
curatrial.com | curatrial.com | 94% | β | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 13 similar websites and full traffic analytics for ProteoGenex
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as ProteoGenex (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ProteoGenex
ProteoGenex was founded in 2003.
ProteoGenex is headquartered in Culver City, United States. It is registered at Culver City, California, United States.
ProteoGenex has 9 employees.
ProteoGenex provides biological materials for biomedical research applications to biotechnology, pharmaceutical, and academic research organizations. The company offers fresh frozen tissue samples; FFPE tissue samples; biofluids, such as blood, bone marrows, urine, saliva, sputum, synovial, and cerebrospinal fluid; RNA and DNA samples; tissue microarrays; human primary cell lines derived from solid tumors and normal tissues; and custom-design human tissue-based research service (largest and fastest growing business segment) for various clinical conditions. It also provides clinical trail services, which include project management, clinical trial monitoring, safety surveillance, CTM and logistics, data management and biostatistics, quality assurance and audits, and regulatory affairs primarily in the areas of oncologyhematology, psychiatry, autoimmune disorders, cardiovascular diseases, and sitesinvestigators identification. The company claims to have over 200,000 individual biomaterials supported by extensive pathology and patient history documentation.
ProteoGenex's top competitors include iSpecimen, GenVault Corporation and ViaCell.
ProteoGenex offers Fresh Frozen Tissues, FFPE Tissues, Blood Products, RNA and DNA, and Custom Collections.
ProteoGenex operates through Proteogenex, Inc..